Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

@article{Sala2004InitialRT,
  title={Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.},
  author={Margarita Sala and Josep M Llovet and Ram{\'o}n Vilana and Llu{\'i}s Bianchi and Manel Sol{\'e} and Carmen Ayuso and Concepci{\'o} Br{\`u} and Jordi Bruix},
  journal={Hepatology},
  year={2004},
  volume={40 6},
  pages={1352-60}
}
Outcome predictors in patients with hepatocellular carcinoma (HCC) who are treated with percutaneous ablation are ill defined, and it is unknown if successful therapy is associated with improved survival. In our study, 282 cirrhotic patients with early nonsurgical HCC were treated with percutaneous ablation during a 15-year period. Single tumors were seen in 244 patients, and 2 to 3 nodules were seen in 38 patients. Initial complete response was achieved in 192 patients and was independently… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 168 extracted citations

Long-Term Outcome of Percutaneous Ablation in Very Early-Stage Hepatocellular Carcinoma

Journal of Gastrointestinal Surgery • 2011
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…